Tetrault, Jeanette M <br/><br/>
Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.  [electronic resource] 

 -  Alcoholism, clinical and experimental research  Feb 2012 
 - 318-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1530-0277 
<br/><br/><label>Standard No.: </label>10.1111/j.1530-0277.2011.01601.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alanine Transaminase--blood<br/>Alcoholism--complications<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>Aspartate Aminotransferases--blood<br/>CD4 Lymphocyte Count<br/>Chemical and Drug Induced Liver Injury--epidemiology<br/>Cohort Studies<br/>Databases, Factual<br/>Drug Interactions<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>HIV Infections--complications<br/>Humans<br/>Liver--enzymology<br/>Liver Function Tests<br/>Male<br/>Middle Aged<br/>Naltrexone--adverse effects<br/>Narcotic Antagonists--adverse effects<br/>Opioid-Related Disorders--complications<br/>RNA, Viral--blood<br/>Veterans